EUVIMEDEUVIMED entdecken
Crossref

Fisetin mitigates letrozole-induced polycystic ovarian syndrome in rats: crosstalk of AMPK/PI3K/AKT-mediated-Nrf2 antioxidant defense mechanism and the inflammasome NLRP3/NF-κB P65/IL-1β signaling pathways

Passant E Moustafa, Nesma M E Abo El Nasr, Marwa E Shabana, Dalia O Saleh

Naunyn-Schmiedeberg's Archives of Pharmacology · 2024

DOI: 10.1007/s00210-024-03124-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2024. Verfasst von Passant E Moustafa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology Department, Medical Research and Clinical Studies Institute, National Research Centre, Giza, Egypt. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Letrozole, NLR Family, Pyrin Domain-Containing 3 Protein, Signal Transduction. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeLetrozoleNLR Family, Pyrin Domain-Containing 3 ProteinSignal TransductionInterleukin-1betaInflammasomesProto-Oncogene Proteins c-aktNF-E2-Related Factor 2FlavonolsAntioxidantsAMP-Activated Protein KinasesAnimalsFemaleRatsTranscription Factor RelARats, WistarPhosphatidylinositol 3-KinasesOvaryFlavonoids

Stichwörter der Autor:innen

FisetinInflammasomeLetrozolePolycystic ovarian syndromeRats

Substanzen

LetrozoleNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, ratInterleukin-1betaInflammasomesProto-Oncogene Proteins c-aktNF-E2-Related Factor 2Nfe2l2 protein, ratfisetinFlavonols

Autor:innen und Institutionen

  • Pharmacology Department, Medical Research and Clinical Studies Institute, National Research Centre, Giza, Egypt.
  • Pharmacology Department, Medical Research and Clinical Studies Institute, National Research Centre, Giza, Egypt. nm.el-nasr@nrc.sci.eg.
  • Pathology Department, Medical Research and Clinical Studies Institute, National Research Centre, Giza, Egypt.

Zitieren

APA

Moustafa, P. E., Abo El Nasr, N. M. E., Shabana, M. E., & Saleh, D. O. (2024). Fisetin mitigates letrozole-induced polycystic ovarian syndrome in rats: crosstalk of AMPK/PI3K/AKT-mediated-Nrf2 antioxidant defense mechanism and the inflammasome NLRP3/NF-κB P65/IL-1β signaling pathways. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-024-03124-5

Vancouver

Moustafa PE, Abo El Nasr NME, Shabana ME, Saleh DO. Fisetin mitigates letrozole-induced polycystic ovarian syndrome in rats: crosstalk of AMPK/PI3K/AKT-mediated-Nrf2 antioxidant defense mechanism and the inflammasome NLRP3/NF-κB P65/IL-1β signaling pathways. Naunyn-Schmiedeberg's Archives of Pharmacology. 2024. doi:10.1007/s00210-024-03124-5

BibTeX
@article{Moustafa2024,
  author = {Moustafa, Passant E and Abo El Nasr, Nesma M E and Shabana, Marwa E and Saleh, Dalia O},
  title = {Fisetin mitigates letrozole-induced polycystic ovarian syndrome in rats: crosstalk of AMPK/PI3K/AKT-mediated-Nrf2 antioxidant defense mechanism and the inflammasome NLRP3/NF-κB P65/IL-1β signaling pathways},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2024},
  doi = {10.1007/s00210-024-03124-5}
}
Kostenlos starten →